Associated Papers
AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer.
Kim S et al.
Elife, 2022
Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity.
Lim WF et al.
Science Advances, 2021
Molecular diagnostics of disorders of sexual development: an Indian survey and systems biology perspective.
Nagaraja MR et al.
Systems Biology in Reproductive Medicine, 2019
The Long-Term Outcome of Boys With Partial Androgen Insensitivity Syndrome and a Mutation in the Androgen Receptor Gene.
Lucas-Herald A et al.
The Journal of Clinical Endocrinology and Metabolism, 2016
Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies.
Chan SC et al.
Nucleic Acids Research, 2015
Phenotype, hormonal profile and genotype of subjects with partial androgen insensitivity syndrome: report of a family with four adult males and one child with disorder of sexual differentiation.
Kulshreshtha B et al.
Andrologia, 2009
RNA editing of androgen receptor gene transcripts in prostate cancer cells.
Martinez HD et al.
The Journal of Biological Chemistry, 2008
Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development.
Moehren U et al.
Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2008
The molecular basis of androgen insensitivity.
Nitsche EM et al.
Hormone Research, 2000
The androgen receptor gene mutations database.
Patterson MN et al.
Nucleic Acids Research, 1994
Mutational Analysis of Androgen Receptor Gene in Two Families with Androgen Insensitivity.
Akella RR
Indian Journal of Endocrinology and Metabolism, 0
Select a paper to view details